Table 1.

Genetic and clinical features of patients enrolled in this study

IDAge (y)*SexGeneVariantAmino acid substitutionBMF presentPeripheral blood abnormalitiesHb (g/dL)WBC
(×109/L)
Platelets (×109/L)Extra-hematopoietic abnormalities
4457 34 FANCA c.2167_2169del/c.3349-1G>C p.Leu723del/p.? Yes Leucopenia 14.4 2.9 207 Skin pigmentation and liver abnormalities 
4462 30 FANCA c.1226-2A>G/ c.1776 + 5G>C p.?/p.? Yes Leucopenia 12.6 2.4 177 Skin pigmentation abnormalities 
4501 22 FANCG c.1158delC p.Ser387ProfsTer16 Yes Leucopenia 13.5 2.7 161 Skin pigmentation abnormalities 
4705 55 DKC1 c.1205G>A p.Gly402Glu Yes High MCV and HbF 13.6 6.2 189 Mucocutaneous abnormalities 
4740 30 DKC1 c.1049T>C p.Met350Thr Yes Thrombocytopenia 14.6 7.5 84 Mucocutaneous abnormalities 
4702 36 DKC1 c.1058C>T p.Ala353Val No None 15.1 9.3 279 Mucocutaneous abnormalities 
4551 22 SBDS c.183_184delins/ c.258 + 2T>C p.Lys62Ter/ p.Cys84TyrfsTer4 Yes Leucopenia, thrombocytopenia 14.2 2.2 103 Short stature, pancreatic insufficiency 
4575 28 SBDS c.183_184delins/ c.258 + 2T>C p.Lys62Ter/ p.Cys84TyrfsTer4 Yes Leucopenia, thrombocytopenia 14.6 2.6 141 Short stature, pancreatic insufficiency 
4642 24 SBDS c.183_184delins/ c.258 + 2T>C p.Lys62Ter/ p.Cys84TyrfsTer4 Yes Leucopenia, thrombocytopenia 14.0 2.1 101 Osteoporosis, short stature, pancreatic insufficiency, telangiectasia 
4504 39 UNK/TRI — — Yes Pancytopenia 8.3 2.6 109 Liver abnormalities 
4545 47 UNK/TRI — — Yes§ Pancytopenia 7.5 2.0 48 None 
4592 26 UNK/TRI — — Yesǁ Pancytopenia 7.9 2.1 9 Premature birth 
4520 17 UNK/SNGL — — Yes Anemia 10.7 6.7 410 Hearing loss, cataract 
4633 47 UNK/SNGL — — Yes Leucopenia 14.2 3.5 197 Dysmorphic facies, high-arched palate, unilateral ptosis 
4680 51 UNK/SNGL — — Yes Leucopenia 13.1 2.3 289 Numerous pigmented freckles, premature gray hair, nail dystrophy 
IDAge (y)*SexGeneVariantAmino acid substitutionBMF presentPeripheral blood abnormalitiesHb (g/dL)WBC
(×109/L)
Platelets (×109/L)Extra-hematopoietic abnormalities
4457 34 FANCA c.2167_2169del/c.3349-1G>C p.Leu723del/p.? Yes Leucopenia 14.4 2.9 207 Skin pigmentation and liver abnormalities 
4462 30 FANCA c.1226-2A>G/ c.1776 + 5G>C p.?/p.? Yes Leucopenia 12.6 2.4 177 Skin pigmentation abnormalities 
4501 22 FANCG c.1158delC p.Ser387ProfsTer16 Yes Leucopenia 13.5 2.7 161 Skin pigmentation abnormalities 
4705 55 DKC1 c.1205G>A p.Gly402Glu Yes High MCV and HbF 13.6 6.2 189 Mucocutaneous abnormalities 
4740 30 DKC1 c.1049T>C p.Met350Thr Yes Thrombocytopenia 14.6 7.5 84 Mucocutaneous abnormalities 
4702 36 DKC1 c.1058C>T p.Ala353Val No None 15.1 9.3 279 Mucocutaneous abnormalities 
4551 22 SBDS c.183_184delins/ c.258 + 2T>C p.Lys62Ter/ p.Cys84TyrfsTer4 Yes Leucopenia, thrombocytopenia 14.2 2.2 103 Short stature, pancreatic insufficiency 
4575 28 SBDS c.183_184delins/ c.258 + 2T>C p.Lys62Ter/ p.Cys84TyrfsTer4 Yes Leucopenia, thrombocytopenia 14.6 2.6 141 Short stature, pancreatic insufficiency 
4642 24 SBDS c.183_184delins/ c.258 + 2T>C p.Lys62Ter/ p.Cys84TyrfsTer4 Yes Leucopenia, thrombocytopenia 14.0 2.1 101 Osteoporosis, short stature, pancreatic insufficiency, telangiectasia 
4504 39 UNK/TRI — — Yes Pancytopenia 8.3 2.6 109 Liver abnormalities 
4545 47 UNK/TRI — — Yes§ Pancytopenia 7.5 2.0 48 None 
4592 26 UNK/TRI — — Yesǁ Pancytopenia 7.9 2.1 9 Premature birth 
4520 17 UNK/SNGL — — Yes Anemia 10.7 6.7 410 Hearing loss, cataract 
4633 47 UNK/SNGL — — Yes Leucopenia 14.2 3.5 197 Dysmorphic facies, high-arched palate, unilateral ptosis 
4680 51 UNK/SNGL — — Yes Leucopenia 13.1 2.3 289 Numerous pigmented freckles, premature gray hair, nail dystrophy 

All patients (except patient 4702) had hypocellular bone marrows. Peripheral blood count values below the normal range are in bold. Full blood counts and lymphocyte subsets within normal ranges are provided in supplemental Table 1.

F, female; Hb, hemoglobin; HbF, fetal hemoglobin; M, male; MCV, mean corpuscular volume; SNGL, single-lineage cytopenia; TRI, trilineage cytopenia; UNK, unknown genetic basis; WBC, white blood cell count.

*

Age at sampling.

Receiving danazol treatment.

Receiving granulocyte colony-stimulating factor treatment.

§

Receiving cyclosporin treatment.

ǁ

Receiving oxymetholone treatment.

Close Modal

or Create an Account

Close Modal
Close Modal